Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
158,915,436
-
Share change
-
+6,492,100
-
Total reported value
-
$1,225,110,060
-
Put/Call ratio
-
251%
-
Price per share
-
$7.71
-
Number of holders
-
216
-
Value change
-
+$50,334,510
-
Number of buys
-
92
-
Number of sells
-
100
Institutional Holders of PDL BIOPHARMA INC COM - COM (Y104L) as of Q4 2014
As of 31 Dec 2014,
PDL BIOPHARMA INC COM - COM (Y104L) was held by
216 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
158,915,436 shares.
The largest 10 holders included
Bank of New York Mellon Corp, BlackRock Fund Advisors, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, FIRST TRUST ADVISORS LP, SCHRODER INVESTMENT MANAGEMENT GROUP, ACADIAN ASSET MANAGEMENT LLC, Advisors Asset Management, Inc., BANK OF AMERICA CORP /DE/, and BlackRock Institutional Trust Company, N.A..
This page lists
216
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.